Hariprasad Vankayalapati,Ph.D.

Board Certification and Academic Information

Academic Office Locations

Academic Bio

Hariprasad Vankayalapati, M Pharm, PhD
Assistant Professor/Chief Scientist, School of Medicine of University of Utah
Dr. Hariprasad is an Assistant Professor/Chief Scientist in Medicinal Chemistry at the Center for Investigational Therapeutics (CIT) and The Huntsman Cancer Institute in Salt Lake City, where he is focused on both the early discovery/design and development of targeted therapeutics for multiple cancer indications. His presence at CIT group of Huntsman Cancer over the last three years led to the discovery of pre-clinical candidates for three protein kinases and an epigenetic target. These projects advanced to enabling studies and currently he is serving on number of collaborative research programs with several investigators on campus. Prior to moving to CIT group in 2009, Dr. Hariprasad was a Director of Medicinal Chemistry and Chief Scientist at the SuperGen Inc. He has helped to initiate the area of Medicinal Chemistry & early discovery, beginning multiple target pipeline programs including protein kinases, epigenetic and transcription factors, as well as creating several product pipeline, CLIMB™ and co-founding Montigen Pharmaceuticals in 2003, later was acquired by SuperGen Inc., (now Astex Pharmaceuticals).
Dr. Hariprasad has published more than 70 peer reviewed publications and over 23 US/WO patents in the past 16 years, focusing primarily in the area of Medicinal, Organic coupled with Computational Chemistry and Structure/Fragment-Based Drug Discovery including involvement in the discovery/development of first in class two clinical candidates currently in Phase I/II trials. He brings over 10 years of experience in the pharmaceutical industry and he is also serving as Scientific Advisor/consultant for Medicinal Chemistry/early discovery project to Pharmaceutical industries. He also served as Associate Scientist at New Drug Discovery Research team at Ranbaxy Laboratories/Daiichi Sankyo, New Delhi.
Dr. Hariprasad obtained his M. Pharm in Pharmaceutical Chemistry and his Ph.D. in Medicinal Chemistry at the Pharmaceutical Division of the University Department of Chemical Technology (UDCT), Mumbai and conducted his Post-Doctoral research in Organic Chemistry in the Chemistry Department at the University of Sunderland, England and Senior Post-Doctoral Fellow/Associate Research Scientist in Medicinal Chemistry at the Arizona Cancer Center of the University of Arizona. His interests include; Oncology, CNS, Inflammation and Diabesity targeted therapeutics development.